SuperworthNEUROONE MEDICAL TECHNOLOGIES market cap NMTC
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $8.4M
- Highest close in our data
- $109.7M
- Mar 2021
NEUROONE MEDICAL TECHNOLOGIES is worth $8.4M at the close on Oct 23, 2026, at $0.92 a share.
That is down 79% over the last year and down 75% over five years.
Its highest close in our data was $109.7M in Mar 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $8.4M | $8.4M | $45.5M | −77% |
| 2025 | $36.8M | $14.5M | $47.5M | +46% |
| 2024 | $25.2M | $18.2M | $36.9M | −33% |
| 2023 | $37.9M | $18.1M | $45.9M | +94% |
| 2022 | $19.5M | $8.6M | $47.9M | −38% |
| 2021 | $31.4M | $24.6M | $109.7M | −13% |
| 2020 | $36.1M | $20.9M | $39.7M | +17% |
| 2019 | $31M | $25.4M | $59.8M | −43% |
| 2018 | $54.3M | $27.4M | $71.9M | n/a |
Against its peers
Companies in Healthcare nearest NEUROONE MEDICAL TECHNOLOGIES' size, closest first, today.
| Company | Market cap |
|---|---|
| NMTCNEUROONE MEDICAL TECHNOLOGIES | $8.4M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $56.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on NEUROONE MEDICAL TECHNOLOGIES
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.